Brief: Lisata Therapeutics Announces Full Enrollment Of Pancreatic Cancer Cohort Of Cendifox Trial
13/06/2024 13:50
June 13 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS ANNOUNCES FULL ENROLLMENT OF
PANCREATIC
CANCER COHORT OF CENDIFOX TRIAL
Source text for Eikon: ID:nGNX8hRJfN
Further company coverage: LSTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco